 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
$ O# A g3 u2 ?, ]" f2 i
9 \2 m7 \! E. x9 z4 ~+ }EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX./ q9 N; t# T, j
) F3 D$ S. s8 |" O- }' `
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007- f3 |6 l/ o4 l& x; f/ G# s' Z8 K
6 O2 k/ x+ k. ]5 U% g ) j# M( d* h- I) ^
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
# F! t0 Q6 S& W1 r8 \5 a
3 b4 z7 w7 o& y$ s, e7 hThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."# v% N" @1 |) e
8 { N4 o) A) M5 m. M# LThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
. z, r$ l6 h/ u( P" ]& N8 x" ^' j) O Y
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
$ P/ ?. A: A, P- V& T) b$ }7 A( D. B1 W5 c& s
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
+ w/ w7 t. i' S* q7 h: `6 g9 H6 \6 n+ B' I* h. y7 V5 R- }" F9 n3 F
"As a scientist, it's one of the highlights of my CAREER," Shan said.* H* W7 Y- T9 d; D! ^: O- d3 U
2 E. j- F9 ]8 e$ i
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
) P7 _( [" |( m& ~3 t& w& M: N8 K. v
9 |8 m, Z: }5 E" r* ^* kIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
4 [7 ]2 f; I- E3 @ p9 F6 H7 C; M: n/ a; j o8 ^2 A2 z* Q) ]( z
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
: ]# V7 g+ i: p# n' s! K! S( n# q4 x* r3 [( y
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.$ A( W+ @) c. _0 a$ p4 U' R& b, _
H+ E+ j2 C' Y2 a X' B
2 H" g: Y7 l. R: Khttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
